inspiriences

HONG KONG SAR - Media OutReach Newswire - 11 June 2025 - Reputed to be a leading research and development (R&D) hub for medical sciences, Hong Kong hosts the world's largest and most significant gathering of stem cell research and regenerative medicine, the International Society of Stem Cell Research (ISSCR) 2025 Annual Meeting. The event is brought to Hong Kong for the first time, thanks to the joint effort of three local universities – The University of Hong Kong, The Chinese University of Hong Kong and the Hong Kong University of Science and Technology, which are appointed organisations under the Hong Kong Convention Ambassador (HKCA) programme of the Hong Kong Tourism Board (HKTB). The four-day meeting held on June 11-14 gathers more than 2,400 local and international experts in stem cell research and regenerative medicine from 58 countries and regions, from Asia to North America, Europe, Australia, the Middle East, and Mainland China. Pioneers share the latest a...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ) Q1 2025 Earnings Call Transcript May 8, 2025 Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.25. Operator: Good day and thank you for standing by. Welcome everyone to the Iovance Biotherapeutics First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Sara Pellegrino, SVP, IR and Corporate Communications. Please go ahead. Sara Pellegrino: Good afternoon and thank you for joining the Iovance conference call and webcast to discuss our first quarter 2025 financial results, as well as recent corporate updates. Dr. Fred Vogt, our Interim Chief Executive Officer a...

NewsVoir New Delhi [India], March 24: Peptech Biosciences Ltd announced the successful acquisition of technology from the National Bureau of Agricultural Insect Resources (NBAIR) in India. This innovative tech centers around an indigenous liquid formulation of toxic strains of Bacillus thuringiensis (Bt). Trials carried out by NBAIR have shown the impressive effectiveness of this technology. Spraying foliar applications of Bacillus thuringiensis NBAIR BtG4 at a rate of 2% significantly decreased pod damage in pigeon peas. Additionally, this method substantially boosted grain yields, underscoring the technology’s promise for improving crop production efficiency with reduced environmental effects. The microbe acts as a Bio-pesticide exhibiting significant toxicity towards H. armigera. P. xylostella , Chilo partellus , Sesamia inferens Leucinodes orbonalis, along with various Lepidoptera species that harm pulses, vegetables, and...